Neosense Technologies AB
Oxygen monitoring system for preterm babies
- First investment year: 2015
- Fund: Stockholm
- Business sector: Life Science

Neosense provides intensive care units for preterm babies with continuous oxygen monitoring systems for improved control and safety. Extremely preterm babies need advanced intensive care due to underdeveloped organs and a weak immune system. The oxygen supply must be controlled to keep blood oxygenation within very narrow limits to minimize the risk for complications. Neosense Technologies has developed a world unique sensor for real-time measurement of blood oxygenation.